Advances and challenges in therapeutic resistant biomarkers of neuroblastoma: A comprehensive review

Y Krithicaa Narayanaa, Amrutha Arjunan, Devi Maigandan, Arun Dharmarajan, Lakshmi Revathi Perumalsamy

Research output: Contribution to journalReview articlepeer-review

Abstract

Therapeutic resistance is one of the significant challenges in Neuroblastoma. Owing to its molecular diversity, the therapeutic resistance mechanisms of Neuroblastoma are highly complicated. The traditional chemo and radio therapeutics fail to provide adequate solutions to the treatment resistance, demanding in-depth research to improvise the existing prognostic and therapeutic regimens. To address this knowledge gap, several investigations are being employed, such as unravelling the molecular signalling mechanisms involved in drug resistance at genomics and proteomics levels, development of biomarkers for assessing the therapeutic success, development of novel drug targets for cancer stem cells, targeted immunotherapy and combination therapies. This review collates the ongoing research efforts to address the challenges faced in Neuroblastoma treatment resistance and uncovers the importance of transitioning biomarker discoveries into clinical practice.

Original languageEnglish
Article number189222
Number of pages19
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1879
Issue number6
Early online date26 Nov 2024
DOIs
Publication statusPublished - Nov 2024

Fingerprint

Dive into the research topics of 'Advances and challenges in therapeutic resistant biomarkers of neuroblastoma: A comprehensive review'. Together they form a unique fingerprint.

Cite this